Blockchain Registration Transaction Record
Tonix Pharmaceuticals Awarded $34 Million Contract with U.S. Department of Defence
Tonix Pharmaceuticals CEO Dr. Seth Lederman announces $34 million contract with the Defense Threat Reduction Agency (DTRA) for the development of broad-spectrum antiviral agents, enhancing medical readiness for military personnel.
The development of broad-spectrum antiviral agents has the potential to significantly impact the way viral infections are managed in military and possibly civilian populations. This news matters as it highlights the commitment to advancing medical readiness and protection for military personnel, addressing the evolving needs of the healthcare and defense sectors.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x6fc3fbec12a6cfb42cd951375f124feff51a15da6c8ed5584e901f08ba0b3ccc |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | gleeUWsd-fe5c2bb8d2d73a6b9590ba94c75aeb61 |